T 1710/09 (Alendronate for osteoporosis/MERCK) of 12.04.2011
- European Case Law Identifier
- ECLI:EP:BA:2011:T171009.20110412
- Date of decision
- 12 April 2011
- Case number
- T 1710/09
- Petition for review of
- -
- Application number
- 01201913.9
- IPC class
- A61K 31/663
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Alendronate for use in the treatment of osteoporosis
- Applicant name
- Merck Sharp & Dohme Corp.
- Opponent name
- PLIVA, Farmaceutska Industrija Dionicko Drustvo + AWD.pharma GmbH & Co. KG
STADA Arzneimittel AG
Hexal AG + Sandoz AG
Arrow International Ltd.
betapharm Arzneimittel GmbH
ZAKLADY FARMACEUTYCZNE POLPHARMA S.A.
Gedeon Richter Plc.
Generics [UK] Ltd. et al
STADA Arzneimittel GmbH
"Interpharm" ProduktionsgmbH
BIOGARAN
Tecnimede, Sociedade Tecnico-Medicinal, S.A.
ACTAVIS GROUP - Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 76(1)
- Keywords
- All requests: added subject-matter (yes)
- Catchword
- -
ORDER
For these reasons it is decided that:
The appeal is dismissed.